DENTSPLY SIRONA Inc. (XRAY)
USD 12.79
(1.07%)
USD 12.79
(1.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.07 Billion USD | 6.4% |
| 2022 | 3.83 Billion USD | -8.28% |
| 2021 | 4.17 Billion USD | -4.46% |
| 2020 | 4.37 Billion USD | 24.63% |
| 2019 | 3.5 Billion USD | -1.29% |
| 2018 | 3.55 Billion USD | -4.94% |
| 2017 | 3.73 Billion USD | 5.9% |
| 2016 | 3.53 Billion USD | 71.08% |
| 2015 | 2.06 Billion USD | -11.36% |
| 2014 | 2.32 Billion USD | -6.88% |
| 2013 | 2.5 Billion USD | -8.18% |
| 2012 | 2.72 Billion USD | -5.17% |
| 2011 | 2.87 Billion USD | 112.99% |
| 2010 | 1.34 Billion USD | 14.15% |
| 2009 | 1.18 Billion USD | -4.97% |
| 2008 | 1.24 Billion USD | 7.2% |
| 2007 | 1.15 Billion USD | 27.76% |
| 2006 | 907.29 Million USD | -22.16% |
| 2005 | 1.16 Billion USD | -13.89% |
| 2004 | 1.35 Billion USD | 2.3% |
| 2003 | 1.32 Billion USD | 5.86% |
| 2002 | 1.24 Billion USD | 5.19% |
| 2001 | 1.18 Billion USD | 247.75% |
| 2000 | 341.68 Million USD | -11.98% |
| 1999 | 388.2 Million USD | -18.92% |
| 1998 | 478.8 Million USD | 38.18% |
| 1997 | 346.5 Million USD | 16.35% |
| 1996 | 297.8 Million USD | 6.97% |
| 1995 | 278.4 Million USD | 58.81% |
| 1994 | 175.3 Million USD | -34.64% |
| 1993 | 268.2 Million USD | 636.81% |
| 1992 | 36.4 Million USD | -25.26% |
| 1991 | 48.7 Million USD | 363.81% |
| 1990 | 10.5 Million USD | 218.18% |
| 1989 | 3.3 Million USD | -15.38% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 3.86 Billion USD | -5.18% |
| 2024 Q2 | 3.83 Billion USD | -0.83% |
| 2023 Q3 | 3.83 Billion USD | -2.99% |
| 2023 Q4 | 4.07 Billion USD | 6.42% |
| 2023 Q1 | 4.03 Billion USD | 5.32% |
| 2023 Q2 | 3.94 Billion USD | -2.16% |
| 2023 FY | 4.07 Billion USD | 6.4% |
| 2022 Q4 | 3.83 Billion USD | -1.97% |
| 2022 Q1 | 4.25 Billion USD | 1.84% |
| 2022 Q3 | 3.9 Billion USD | -4.91% |
| 2022 Q2 | 4.11 Billion USD | -3.39% |
| 2022 FY | 3.83 Billion USD | -8.28% |
| 2021 Q1 | 4.2 Billion USD | -3.77% |
| 2021 Q4 | 4.17 Billion USD | 0.34% |
| 2021 Q3 | 4.16 Billion USD | -3.21% |
| 2021 FY | 4.17 Billion USD | -4.46% |
| 2021 Q2 | 4.3 Billion USD | 2.23% |
| 2020 Q2 | 3.95 Billion USD | 17.53% |
| 2020 Q3 | 4.13 Billion USD | 4.42% |
| 2020 Q4 | 4.37 Billion USD | 5.77% |
| 2020 FY | 4.37 Billion USD | 24.63% |
| 2020 Q1 | 3.36 Billion USD | -3.99% |
| 2019 FY | 3.5 Billion USD | -1.29% |
| 2019 Q4 | 3.5 Billion USD | 6.06% |
| 2019 Q2 | 3.39 Billion USD | -2.94% |
| 2019 Q3 | 3.3 Billion USD | -2.5% |
| 2019 Q1 | 3.49 Billion USD | -1.66% |
| 2018 Q3 | 3.61 Billion USD | -1.82% |
| 2018 Q2 | 3.68 Billion USD | 0.39% |
| 2018 Q1 | 3.66 Billion USD | -1.9% |
| 2018 Q4 | 3.55 Billion USD | -1.68% |
| 2018 FY | 3.55 Billion USD | -4.94% |
| 2017 Q1 | 3.43 Billion USD | -2.83% |
| 2017 FY | 3.73 Billion USD | 5.9% |
| 2017 Q4 | 3.73 Billion USD | 0.79% |
| 2017 Q3 | 3.7 Billion USD | 3.73% |
| 2017 Q2 | 3.57 Billion USD | 4.24% |
| 2016 Q4 | 3.53 Billion USD | -1.81% |
| 2016 Q3 | 3.59 Billion USD | 14.65% |
| 2016 Q1 | 3.29 Billion USD | 59.78% |
| 2016 FY | 3.53 Billion USD | 71.08% |
| 2016 Q2 | 3.13 Billion USD | -4.89% |
| 2015 Q2 | 2.18 Billion USD | -1.36% |
| 2015 Q1 | 2.21 Billion USD | -5.05% |
| 2015 FY | 2.06 Billion USD | -11.36% |
| 2015 Q4 | 2.06 Billion USD | -2.7% |
| 2015 Q3 | 2.12 Billion USD | -2.74% |
| 2014 Q1 | 2.56 Billion USD | 2.59% |
| 2014 Q3 | 2.38 Billion USD | -4.01% |
| 2014 FY | 2.32 Billion USD | -6.88% |
| 2014 Q4 | 2.32 Billion USD | -2.5% |
| 2014 Q2 | 2.48 Billion USD | -3.01% |
| 2013 Q4 | 2.5 Billion USD | -1.22% |
| 2013 Q1 | 2.63 Billion USD | -3.31% |
| 2013 Q2 | 2.58 Billion USD | -1.75% |
| 2013 Q3 | 2.53 Billion USD | -2.15% |
| 2013 FY | 2.5 Billion USD | -8.18% |
| 2012 FY | 2.72 Billion USD | -5.17% |
| 2012 Q1 | 2.96 Billion USD | 3.37% |
| 2012 Q2 | 2.88 Billion USD | -2.91% |
| 2012 Q3 | 2.81 Billion USD | -2.26% |
| 2012 Q4 | 2.72 Billion USD | -3.33% |
| 2011 FY | 2.87 Billion USD | 112.99% |
| 2011 Q4 | 2.87 Billion USD | -2.45% |
| 2011 Q3 | 2.94 Billion USD | 86.83% |
| 2011 Q2 | 1.57 Billion USD | 8.31% |
| 2011 Q1 | 1.45 Billion USD | 7.9% |
| 2010 Q3 | 1.31 Billion USD | 24.88% |
| 2010 Q2 | 1.05 Billion USD | -4.37% |
| 2010 FY | 1.34 Billion USD | 14.15% |
| 2010 Q4 | 1.34 Billion USD | 2.23% |
| 2010 Q1 | 1.1 Billion USD | -6.51% |
| 2009 Q1 | 1.08 Billion USD | -12.99% |
| 2009 Q3 | 1.16 Billion USD | 6.42% |
| 2009 Q4 | 1.18 Billion USD | 1.4% |
| 2009 FY | 1.18 Billion USD | -4.97% |
| 2009 Q2 | 1.09 Billion USD | 1.22% |
| 2008 Q2 | 1.38 Billion USD | -0.79% |
| 2008 Q3 | 1.07 Billion USD | -22.34% |
| 2008 Q4 | 1.24 Billion USD | 15.65% |
| 2008 FY | 1.24 Billion USD | 7.2% |
| 2008 Q1 | 1.39 Billion USD | 20.32% |
| 2007 FY | 1.15 Billion USD | 27.76% |
| 2007 Q1 | 956.49 Million USD | 5.42% |
| 2007 Q2 | 989.83 Million USD | 3.49% |
| 2007 Q4 | 1.15 Billion USD | -0.16% |
| 2007 Q3 | 1.16 Billion USD | 17.29% |
| 2006 Q1 | 1.13 Billion USD | -2.84% |
| 2006 Q2 | 1.31 Billion USD | 16.21% |
| 2006 Q3 | 1.28 Billion USD | -2.66% |
| 2006 Q4 | 907.29 Million USD | -29.18% |
| 2006 FY | 907.29 Million USD | -22.16% |
| 2005 Q1 | 1.26 Billion USD | -6.76% |
| 2005 FY | 1.16 Billion USD | -13.89% |
| 2005 Q3 | 1.2 Billion USD | 0.45% |
| 2005 Q4 | 1.16 Billion USD | -3.63% |
| 2005 Q2 | 1.2 Billion USD | -4.6% |
| 2004 FY | 1.35 Billion USD | 2.3% |
| 2004 Q1 | 1.3 Billion USD | -1.64% |
| 2004 Q2 | 1.27 Billion USD | -1.76% |
| 2004 Q3 | 1.3 Billion USD | 2.1% |
| 2004 Q4 | 1.35 Billion USD | 3.7% |
| 2003 FY | 1.32 Billion USD | 5.86% |
| 2003 Q4 | 1.32 Billion USD | 1.98% |
| 2003 Q3 | 1.29 Billion USD | -2.07% |
| 2003 Q2 | 1.32 Billion USD | 2.62% |
| 2003 Q1 | 1.29 Billion USD | 3.3% |
| 2002 Q2 | 1.23 Billion USD | 5.04% |
| 2002 FY | 1.24 Billion USD | 5.19% |
| 2002 Q1 | 1.17 Billion USD | -0.98% |
| 2002 Q4 | 1.24 Billion USD | 0.75% |
| 2002 Q3 | 1.24 Billion USD | 0.38% |
| 2001 Q3 | 623.39 Million USD | 4.63% |
| 2001 Q1 | 534.87 Million USD | 56.54% |
| 2001 FY | 1.18 Billion USD | 247.75% |
| 2001 Q2 | 595.79 Million USD | 11.39% |
| 2001 Q4 | 1.18 Billion USD | 90.6% |
| 2000 Q4 | 341.68 Million USD | -4.36% |
| 2000 Q2 | 367.73 Million USD | -2.35% |
| 2000 Q1 | 376.58 Million USD | -2.99% |
| 2000 FY | 341.68 Million USD | -11.98% |
| 2000 Q3 | 357.27 Million USD | -2.85% |
| 1999 FY | 388.2 Million USD | -18.92% |
| 1999 Q3 | 424 Million USD | -4.78% |
| 1999 Q4 | 388.2 Million USD | -8.44% |
| 1999 Q1 | 457.3 Million USD | -4.49% |
| 1999 Q2 | 445.3 Million USD | -2.62% |
| 1998 Q2 | 449.8 Million USD | 25.4% |
| 1998 Q4 | 478.8 Million USD | 5.02% |
| 1998 Q3 | 455.9 Million USD | 1.36% |
| 1998 Q1 | 358.7 Million USD | 3.52% |
| 1998 FY | 478.8 Million USD | 38.18% |
| 1997 FY | 346.5 Million USD | 16.35% |
| 1997 Q1 | 363.3 Million USD | 21.99% |
| 1997 Q2 | 346.4 Million USD | -4.65% |
| 1997 Q3 | 349.3 Million USD | 0.84% |
| 1997 Q4 | 346.5 Million USD | -0.8% |
| 1996 Q1 | 323.8 Million USD | 16.31% |
| 1996 FY | 297.8 Million USD | 6.97% |
| 1996 Q2 | 318.6 Million USD | -1.61% |
| 1996 Q3 | 311.7 Million USD | -2.17% |
| 1996 Q4 | 297.8 Million USD | -4.46% |
| 1995 Q3 | 276.8 Million USD | -7.39% |
| 1995 Q2 | 298.9 Million USD | 37.43% |
| 1995 FY | 278.4 Million USD | 58.81% |
| 1995 Q4 | 278.4 Million USD | 0.58% |
| 1995 Q1 | 217.5 Million USD | 24.07% |
| 1994 FY | 175.3 Million USD | -34.64% |
| 1994 Q1 | 242.3 Million USD | -9.66% |
| 1994 Q2 | 232.8 Million USD | -3.92% |
| 1994 Q3 | 217.3 Million USD | -6.66% |
| 1994 Q4 | 175.3 Million USD | -19.33% |
| 1993 Q3 | 378 Million USD | -0.84% |
| 1993 FY | 268.2 Million USD | 636.81% |
| 1993 Q1 | 55.3 Million USD | -0.72% |
| 1993 Q2 | 381.2 Million USD | 589.33% |
| 1993 Q4 | 268.2 Million USD | -29.05% |
| 1992 Q2 | 41 Million USD | 12.64% |
| 1992 Q3 | 56 Million USD | 36.59% |
| 1992 Q1 | 36.4 Million USD | 39.46% |
| 1992 FY | 36.4 Million USD | -25.26% |
| 1992 Q4 | 55.7 Million USD | -0.54% |
| 1991 Q2 | 47.3 Million USD | -2.87% |
| 1991 FY | 48.7 Million USD | 363.81% |
| 1991 Q3 | 40.9 Million USD | -13.53% |
| 1991 Q4 | 26.1 Million USD | -36.19% |
| 1991 Q1 | 48.7 Million USD | -13.65% |
| 1990 Q1 | 10.5 Million USD | -10.26% |
| 1990 FY | 10.5 Million USD | 218.18% |
| 1990 Q2 | 5.4 Million USD | -48.57% |
| 1990 Q3 | 57.4 Million USD | 962.96% |
| 1990 Q4 | 56.4 Million USD | -1.74% |
| 1989 Q1 | 3.3 Million USD | 0.0% |
| 1989 FY | 3.3 Million USD | -15.38% |
| 1989 Q3 | 12.2 Million USD | 0.0% |
| 1989 Q2 | 12.2 Million USD | 269.7% |
| 1989 Q4 | 11.7 Million USD | -4.1% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | -3119.615% |
| AngioDynamics, Inc. | 112.08 Million USD | -3536.526% |
| AtriCure, Inc. | 147.76 Million USD | -2658.453% |
| Avinger, Inc. | 19.97 Million USD | -20308.572% |
| Azenta, Inc. | 351.22 Million USD | -1060.526% |
| BioLife Solutions, Inc. | 75.05 Million USD | -5330.974% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 0.777% |
| Daxor Corporation | 858.75 Thousand USD | -474538.955% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -24887.739% |
| Femasys Inc. | 9.4 Million USD | -43246.78% |
| GlucoTrack, Inc. | 1.7 Million USD | -238541.686% |
| Harvard Bioscience, Inc. | 64.29 Million USD | -6239.825% |
| Hologic, Inc. | 4.02 Billion USD | -1.242% |
| ICU Medical, Inc. | 2.25 Billion USD | -80.752% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -99.393% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -50176.291% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -8239.13% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -617535.65% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -617535.65% |
| Masimo Corporation | 1.67 Billion USD | -143.097% |
| Microbot Medical Inc. | 3.82 Million USD | -106434.239% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -16153.646% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | -262.878% |
| Nephros, Inc. | 3.5 Million USD | -116257.408% |
| NovoCure Limited | 783.63 Million USD | -420.141% |
| NEXGEL, Inc. | 4.78 Million USD | -85011.714% |
| NEXGEL, Inc. | 4.78 Million USD | -85011.714% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | -4614.264% |
| OraSure Technologies, Inc. | 52.17 Million USD | -7712.32% |
| Pro-Dex, Inc. | 23.34 Million USD | -17361.337% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -24687.158% |
| Predictive Oncology Inc. | 6.14 Million USD | -66225.288% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -59448.976% |
| QuidelOrtho Corporation | 3.55 Billion USD | -14.585% |
| Repligen Corporation | 853.2 Million USD | -377.726% |
| Sanara MedTech Inc. | 29.28 Million USD | -13819.276% |
| STAAR Surgical Company | 102.73 Million USD | -3867.373% |
| Sharps Technology, Inc. | 3.85 Million USD | -105633.308% |
| Utah Medical Products, Inc. | 7.14 Million USD | -56946.886% |
| Jin Medical International Ltd. | 8.92 Million USD | -45572.82% |